Yasu-Taka Azuma

6PUBLICATIONS
15CO-AUTHORS
Medical biochemistry - lipidsTraditional Chinese medicine and treatmentsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2024
Inhibition of Drp1-Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria-Lipid Droplet Contact.

Kohei Ariyoshi, Kazuhiro Nishiyama, Yuri Kato

|Feb 24, 2024
Pharmacological Activation of TRPC6 Channel Prevents Colitis Progression.

Kazuhiro Nishiyama, Yuri Kato, Akiyuki Nishimura

|Jan 11, 2022
Redox-dependent internalization of the purinergic P2Y<sub>6</sub> receptor limits colitis progression.

Kazuhiro Nishiyama, Akiyuki Nishimura, Kakeru Shimoda

|Dec 24, 2021
IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.

Yasu-Taka Azuma, Takashi Fujita, Takeshi Izawa

|Oct 15, 2018
Chronic kidney disease after 5/6 nephrectomy disturbs the intestinal microbiota and alters intestinal motility.

Kazuhiro Nishiyama, Kimiya Aono, Yasuyuki Fujimoto

Pageof 1